MolNFT v1 · #64070 · protein
P38 kinase crystal structure in complex with RO6257
3FSK · Mitogen-activated protein kinase 14: “P38 kinase crystal structure in complex with RO6257”. X-ray diffraction, 1 ligand (RO6), 5 pockets (best druggability 0.69). MolNFT v1 #64070 on GenesisL1: 3D structure, binding sites and…
- PDB
- 3FSK
- Type
- protein
- Length
- 342 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Mitogen-activated protein kinase 14
- EC
- 2.7.11.24
- UniProt
- Q16539
- Ligands
- RO6
- Pockets
- 5 · best druggability 0.69
Structure
x-ray diffraction · 1 distinct chain · 42% helix, 15% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Mitogen-activated protein kinase 14 (EC 2.7.11.24) | protein | 342 | 42% helix, 15% strand | Q16539 |
Ligands and binding sites
- RO6 · 3-(2-chlorophenyl)-7-[(trans-4-hydroxycyclohexyl)amino]-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one · ligand · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 452 | 0.69 | 0.80 | 51 | RO6 |
| 2 | 87 | 0.35 | 0.74 | 18 | empty |
| 3 | 52 | 0.33 | 0.78 | 17 | empty |
| 4 | 51 | 0.28 | 0.74 | 13 | empty |
| 5 | 52 | 0.25 | 0.73 | 17 | empty |
Compared structures
- 3FSK · P38 kinase crystal structure in complex with RO6257 · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q16539
- Elsewhere: RCSB PDB 3FSK · PDBe 3FSK · UniProt Q16539
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.